These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 26324014

  • 1. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
    Imöhl M, Reinert RR, van der Linden M.
    Int J Med Microbiol; 2015 Oct; 305(7):776-83. PubMed ID: 26324014
    [Abstract] [Full Text] [Related]

  • 2. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 3. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
    Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W.
    Pediatr Infect Dis J; 2013 Jun 31; 32(6):604-9. PubMed ID: 23348816
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM, Memish ZA, Al-Kattan KM.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [Abstract] [Full Text] [Related]

  • 5. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
    Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M.
    J Infect Dis; 2012 Feb 01; 205(3):401-11. PubMed ID: 22158567
    [Abstract] [Full Text] [Related]

  • 6. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G, Lebanese Inter-Hospital Pneumococcal Surveillance Program.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [Abstract] [Full Text] [Related]

  • 7. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.
    Tomczyk S, Lynfield R, Schaffner W, Reingold A, Miller L, Petit S, Holtzman C, Zansky SM, Thomas A, Baumbach J, Harrison LH, Farley MM, Beall B, McGee L, Gierke R, Pondo T, Kim L.
    Clin Infect Dis; 2016 May 01; 62(9):1119-25. PubMed ID: 26908787
    [Abstract] [Full Text] [Related]

  • 8. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.
    Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268
    [Abstract] [Full Text] [Related]

  • 9. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ.
    Clin Microbiol Infect; 2009 Apr 02; 15 Suppl 3():4-6. PubMed ID: 19366362
    [Abstract] [Full Text] [Related]

  • 10. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
    van der Linden M, Falkenhorst G, Perniciaro S, Imöhl M.
    PLoS One; 2015 Apr 02; 10(7):e0131494. PubMed ID: 26132078
    [Abstract] [Full Text] [Related]

  • 11. Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: A 10-year study of impact of pneumococcal conjugate vaccines.
    Mokaddas E, Albert MJ.
    Expert Rev Vaccines; 2016 Oct 02; 15(10):1337-45. PubMed ID: 27267070
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R.
    Vaccine; 2012 Aug 31; 30(40):5880-5. PubMed ID: 22771186
    [Abstract] [Full Text] [Related]

  • 14. Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010.
    Kobayashi M, Conklin LM, Bigogo G, Jagero G, Hampton L, Fleming-Dutra KE, Junghae M, Carvalho MD, Pimenta F, Beall B, Taylor T, Laserson KF, Vulule J, Van Beneden C, Kim L, Feikin DR, Whitney CG, Breiman RF.
    BMC Infect Dis; 2017 Jan 05; 17(1):25. PubMed ID: 28056828
    [Abstract] [Full Text] [Related]

  • 15. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
    Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O.
    BMC Infect Dis; 2015 Feb 14; 15():61. PubMed ID: 25885764
    [Abstract] [Full Text] [Related]

  • 16. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL, De La Hoz F, Díaz PL, Sanabria O, Realpe ME, Moreno J.
    Vaccine; 2013 Aug 20; 31(37):4033-8. PubMed ID: 23680440
    [Abstract] [Full Text] [Related]

  • 17. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health.
    Pediatr Infect Dis J; 2010 Apr 20; 29(4):289-93. PubMed ID: 19935447
    [Abstract] [Full Text] [Related]

  • 18. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

  • 19. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age.
    Imöhl M, Reinert RR, van der Linden M.
    Clin Microbiol Infect; 2009 Nov 16; 15(11):1008-12. PubMed ID: 19681946
    [Abstract] [Full Text] [Related]

  • 20. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R.
    Clin Microbiol Infect; 2009 Apr 16; 15 Suppl 3():16-20. PubMed ID: 19366365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.